Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Clin Infect Dis. 2023 Mar 4;76(5):795-799. doi: 10.1093/cid/ciac843.
We compared the rapid plasma reagin (RPR) titer on the day of initial presentation with that on the day of syphilis treatment to inform clinical practice as to whether a repeated RPR test should be recommended.
We undertook a retrospective study between 1 March 2011 and 31 December 2020 at the Melbourne Sexual Health Centre in Australia among individuals who underwent syphilis serology on the day of initial presentation and the day of treatment, if the latter were within 14 days after initial presentation. We calculated the percentage of individuals with a ≥4-fold change in RPR titer, stratified by the time between initial presentation and treatment and by syphilis stage.
Among the 766 included syphilis cases, the median duration between initial presentation and treatment was 6 days (interquartile range, 5-7 days). Of these cases, 14.8% (n = 113) had a ≥4-fold increase or decrease during this interval. The number of cases with a ≥4-fold increase or decrease in RPR titer increased with increasing time between initial presentation and treatment, from 5.7% (n = 6) 1-3 days after initial presentation to 26.2% (n = 27) at 10-14 days (Ptrend < .001). There was no significant difference in the number of cases with a ≥4-fold increase or decrease in RPR titer between syphilis stages (P = .66).
Our data support the recommendation of repeating the RPR titer if the day of initial presentation and the day of treatment are different, even when treatment is within a few days after initial presentation.
我们比较了初次就诊时的快速血浆反应素(RPR)滴度与梅毒治疗时的滴度,以便为临床实践提供信息,即是否应建议重复进行 RPR 检测。
我们在澳大利亚墨尔本性健康中心进行了一项回顾性研究,纳入了 2011 年 3 月 1 日至 2020 年 12 月 31 日期间初次就诊当天和治疗当天(如果治疗在初次就诊后 14 天内)进行梅毒血清学检查的个体。我们按初次就诊和治疗之间的时间以及梅毒分期,计算 RPR 滴度变化≥4 倍的个体比例。
在纳入的 766 例梅毒病例中,初次就诊和治疗之间的中位时间为 6 天(四分位距,5-7 天)。这些病例中,14.8%(n = 113)在这一期间 RPR 滴度变化≥4 倍。随着初次就诊和治疗之间的时间增加,RPR 滴度变化≥4 倍的病例数增加,从初次就诊后 1-3 天的 5.7%(n = 6)增加到 10-14 天的 26.2%(n = 27)(趋势 P <.001)。在 RPR 滴度变化≥4 倍的病例数方面,各期梅毒之间无显著差异(P =.66)。
我们的数据支持在初次就诊日和治疗日不同时,即使治疗在初次就诊后几天内进行,也建议重复进行 RPR 滴度检测的建议。